Research Report On Treatment Drug Of Cerebrovascular DiseaseSunFAITH China Ltd.July 13, 2009 9 Pages - SKU: CJFQ2404045 |
| Countries covered: China Cerebrovascular disease is one of the three fatal diseases in our country; urban cerebrovascular disease ranks the second in the causes of death, second only to malignant tumor. With people’s growing awareness and knowledge of the cerebrovascular disease, treatment drug of cerebrovascular disease got rapid development in China, in 2008, growth rate of treatment drug market of cerebrovascular disease reached about 30%. This report analyzes the classification, market development scale and drug demand market of cerebrovascular disease. Besides, it studies the drug markets of ischemic cerebrovascular disease and hemorrhagic cerebrovascular disease. |
More China Cardiovascular Reports
China Cardiovascular Surgery Market - Present and Future Trends Until 2018 by
ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular surgery in China through 2018. The product categories covered in ...
China Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018 by
ABMRG
This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in China through 2018. The product categories covered ...
Cardiovascular and Metabolic Diseases Market Access in China by
Datamonitor
The large and growing number of cardiovascular and metabolic diseases (CVMDs) patients in China translates into significant ...
Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 by
Axis Research Mind
BRICSS Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past ...
Chinese Markets for Cardiovascular Drugs by
Asia Market Information & Development Company
China's demand for Cardiovascular Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Cardiovascular Reports
- Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
- Cardiovascular Partnering Terms and Agreements
- International Stroke Conference 2012 - Post-Conference Review and Analysis
- 6th Asian Pacific Congress of Heart Failure (APCHF) - Post-Conference Review and Analysis
- Arrhythmias Global Clinical Trials Review, H1, 2012

